{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:18:18Z","timestamp":1793683098600,"version":"4.5.1"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,21]],"date-time":"2027-05-21T00:00:00Z","timestamp":1810857600000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["1022604"],"award-info":[{"award-number":["1022604"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["GT15655"],"award-info":[{"award-number":["GT15655"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","award":["IRG-21-146-25"],"award-info":[{"award-number":["IRG-21-146-25"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001449"],"award-info":[{"award-number":["UL1TR001449"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM144834"],"award-info":[{"award-number":["T32 GM144834"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM121176"],"award-info":[{"award-number":["P20GM121176"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.metabol.2026.156652","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:37:53Z","timestamp":1779259073000},"page":"156652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Gut-liver metabolic and enterohormonal remodeling drives progression from metabolic dysfunction-associated steatotic liver disease to steatohepatitis"],"prefix":"10.1016","volume":"181","author":[{"given":"Jaclyn A.","family":"Rivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria C.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveena","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Yahia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siem S.","family":"Goitom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron S.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal Madera","family":"Enriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna B.","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithvi R.","family":"Akepati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredine T.","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama R.","family":"Gullapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuguang","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie G.","family":"In","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie R.","family":"McReynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo F.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2026.156652_bb0005","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021","volume":"7","author":"Feng","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.metabol.2026.156652_bb0010","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol."},{"key":"10.1016\/j.metabol.2026.156652_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw Open."},{"issue":"5","key":"10.1016\/j.metabol.2026.156652_bb0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41575-025-01045-z","article-title":"Metabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment","volume":"22","author":"Byrne","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2026.156652_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156004","article-title":"Metabolic dysfunction-associated steatotic liver disease and its link to cancer","volume":"160","author":"Kalligeros","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156652_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156014","article-title":"Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers","volume":"160","author":"Mantovani","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156652_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156080","article-title":"An updated overview on hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease: trends, pathophysiology and risk-based surveillance","volume":"162","author":"Armandi","year":"2025","journal-title":"Metabolism"},{"issue":"1399\u2013408","key":"10.1016\/j.metabol.2026.156652_bb0040","article-title":"Important role of the GLP-1 axis for glucose homeostasis after bariatric surgery","volume":"26","author":"Larraufie","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.metabol.2026.156652_bb0045","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"issue":"1255\u201364","key":"10.1016\/j.metabol.2026.156652_bb0050","article-title":"Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes","volume":"22","author":"Yen","year":"2024","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.metabol.2026.156652_bb0055","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1038\/s41598-025-89408-z","article-title":"Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes","volume":"15","author":"Havranek","year":"2025","journal-title":"Sci Rep."},{"key":"10.1016\/j.metabol.2026.156652_bb0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/apt.12149","article-title":"Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program","volume":"37","author":"Armstrong","year":"2013","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.metabol.2026.156652_bb0065","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2026.156652_bb0070","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","article-title":"A randomized, controlled trial of liraglutide for adolescents with obesity","volume":"382","author":"Kelly","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.metabol.2026.156652_bb0075","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.metabol.2026.156652_bb0080","first-page":"8","article-title":"Transforming steatotic liver disease management: the emerging role of GLP-1 receptor agonists","author":"Jensen","year":"2024","journal-title":"Hepatol Commun."},{"key":"10.1016\/j.metabol.2026.156652_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2026.156493","article-title":"Proteomic effects of short-term liraglutide vs. placebo in a blinded crossover RCT: Implications for efficacy, safety, and comparison with semaglutide","volume":"177","author":"Stefanakis","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156652_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156433","article-title":"GLP-1RAs and tirzepatide may reduce heart failure risk in obese but not in non-obese patients with cardiovascular or renal disease: a systematic review and meta-analysis","volume":"175","author":"Zhang","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156652_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156652_bb0100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S2213-8587(22)00085-7","article-title":"Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial","volume":"10","author":"Heise","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.metabol.2026.156652_bb0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med."},{"key":"10.1016\/j.metabol.2026.156652_bb0110","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/172810a0","article-title":"Detection of 5-hydroxytryptamine in mammalian enterochromaffin cells","volume":"172","author":"Barter","year":"1953","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156652_bb0115","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/169800b0","article-title":"Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine","volume":"169","author":"Erspamer","year":"1952","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156652_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30703","article-title":"The janus face of serotonin: regenerative promoter and chronic liver disease aggravator","volume":"10","author":"Mao","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.metabol.2026.156652_bb0125","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1038\/s41467-018-07287-7","article-title":"Serotonin signals through a gut-liver axis to regulate hepatic steatosis","volume":"9","author":"Choi","year":"2018","journal-title":"Nat Commun."},{"key":"10.1016\/j.metabol.2026.156652_bb0130","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fphar.2020.00553","article-title":"Gut-derived serotonin contributes to the progression of non-alcoholic steatohepatitis via the liver HTR2A\/PPARgamma2 pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.metabol.2026.156652_bb0135","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/en.2016-1839","article-title":"The diverse metabolic roles of peripheral serotonin","volume":"158","author":"Martin","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2026.156652_bb0140","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MOL.0b013e3283462273","article-title":"Role of peripheral serotonin in glucose and lipid metabolism","volume":"22","author":"Watanabe","year":"2011","journal-title":"Curr Opin Lipidol."},{"key":"10.1016\/j.metabol.2026.156652_bb0145","article-title":"The mechanism of secretion and metabolism of gut-derived 5-hydroxytryptamine","volume":"22","author":"Liu","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.metabol.2026.156652_bb0150","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4254\/wjh.v8.i16.673","article-title":"Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy","volume":"8","author":"Kristiansen","year":"2016","journal-title":"World J Hepatol."},{"key":"10.1016\/j.metabol.2026.156652_bb0155","doi-asserted-by":"crossref","first-page":"G762","DOI":"10.1152\/ajpgi.00476.2011","article-title":"Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice","volume":"302","author":"Trevaskis","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"10.1016\/j.metabol.2026.156652_bb0160","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.chom.2009.03.011","article-title":"Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine","volume":"5","author":"Raffatellu","year":"2009","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.metabol.2026.156652_bb0165","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/j.gastro.2006.05.051","article-title":"Effects of mouse and human lipocalin homologues 24p3\/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair","volume":"131","author":"Playford","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2026.156652_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044328","article-title":"Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation","volume":"7","author":"Chassaing","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.metabol.2026.156652_bb0175","first-page":"39","article-title":"RaMP-DB 2.0: a renovated knowledgebase for deriving biological and chemical insight from metabolites, proteins, and genes","author":"Braisted","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.metabol.2026.156652_bb0180","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.metabol.2026.156652_bb0185","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/bioinformatics\/btw187","article-title":"DyNet: visualization and analysis of dynamic molecular interaction networks","volume":"32","author":"Goenawan","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.metabol.2026.156652_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156237","article-title":"Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver","volume":"168","author":"Gruevska","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156652_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156063","article-title":"Serum lipidomic signatures in patients with varying histological severity of metabolic-dysfunction associated steatotic liver disease","volume":"162","author":"Muralidharan","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156652_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156051","article-title":"Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression","volume":"162","author":"Vouilloz","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156652_bb0205","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/dom.12648","article-title":"Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion","volume":"18","author":"Hansen","year":"2016","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.metabol.2026.156652_bb0210","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2005.01.139","article-title":"Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1","volume":"329","author":"Katsuma","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.metabol.2026.156652_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102759","article-title":"Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes","volume":"55","author":"Calderon","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.metabol.2026.156652_bb0220","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1476-5381.2011.01561.x","article-title":"Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion","volume":"165","author":"Parker","year":"2012","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.metabol.2026.156652_bb0225","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00010.2019","article-title":"Bile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents","volume":"316","author":"Christiansen","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"10.1016\/j.metabol.2026.156652_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286726","article-title":"Ability of high fat diet to induce liver pathology correlates with the level of linoleic acid and Vitamin E in the diet","volume":"18","author":"Graham","year":"2023","journal-title":"PLoS One."},{"key":"10.1016\/j.metabol.2026.156652_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-11-1","article-title":"Palmitic and linoleic acids induce ER stress and apoptosis in hepatoma cells","volume":"11","author":"Zhang","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.metabol.2026.156652_bb0240","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1194\/jlr.M007096","article-title":"Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"51","author":"Feldstein","year":"2010","journal-title":"J Lipid Res."},{"key":"10.1016\/j.metabol.2026.156652_bb0245","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ajpath.2010.11.059","article-title":"Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5\u2019-deoxy-5\u2019-methylthioadenosine (MTA)","volume":"178","author":"Kirovski","year":"2011","journal-title":"Am J Pathol."},{"key":"10.1016\/j.metabol.2026.156652_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080703","article-title":"Expression and function of methylthioadenosine phosphorylase in chronic liver disease","volume":"8","author":"Czech","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.metabol.2026.156652_bb0255","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2362.2000.00615.x","article-title":"Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes","volume":"30","author":"Benz","year":"2000","journal-title":"Eur J Clin Invest."},{"key":"10.1016\/j.metabol.2026.156652_bb0260","first-page":"4058","article-title":"Role of bile acids in the diagnosis and progression of liver cirrhosis: a prospective observational study","volume":"18","author":"Liu","year":"2019","journal-title":"Exp Ther Med."},{"key":"10.1016\/j.metabol.2026.156652_bb0265","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3748\/wjg.v17.i2.164","article-title":"Switching-on of serotonergic calcium signaling in activated hepatic stellate cells","volume":"17","author":"Park","year":"2011","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.metabol.2026.156652_bb0270","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/nm.2490","article-title":"Stimulating healthy tissue regeneration by targeting the 5-HT(2)B receptor in chronic liver disease","volume":"17","author":"Ebrahimkhani","year":"2011","journal-title":"Nat Med."},{"key":"10.1016\/j.metabol.2026.156652_bb0275","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2353\/ajpath.2006.050767","article-title":"A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis","volume":"169","author":"Ruddell","year":"2006","journal-title":"Am J Pathol."},{"key":"10.1016\/j.metabol.2026.156652_bb0280","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.metabol.2019.04.014","article-title":"The incretin system in healthy humans: the role of GIP and GLP-1","volume":"96","author":"Holst","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156652_bb0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5009\/gnl.2012.6.1.10","article-title":"Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity","volume":"6","author":"De Silva","year":"2012","journal-title":"Gut Liver"},{"issue":"Suppl. 3","key":"10.1016\/j.metabol.2026.156652_bb0290","article-title":"The physiology of amylin and insulin: maintaining the balance between glucose secretion and glucose uptake","volume":"32","author":"Martin","year":"2006","journal-title":"Diabetes Educ."},{"key":"10.1016\/j.metabol.2026.156652_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2025.171367","article-title":"The role of leptin and ghrelin in the regulation of appetite in obesity","volume":"186","author":"Skoracka","year":"2025","journal-title":"Peptides"},{"key":"10.1016\/j.metabol.2026.156652_bb0300","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.mol.0000217899.59820.9a","article-title":"Resistin","volume":"17","author":"McTernan","year":"2006","journal-title":"Curr Opin Lipidol."},{"key":"10.1016\/j.metabol.2026.156652_bb0305","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/00365510601032532","article-title":"Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus","volume":"67","author":"Mojiminiyi","year":"2007","journal-title":"Scand J Clin Lab Invest."},{"key":"10.1016\/j.metabol.2026.156652_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087488","article-title":"Glucose-induced glucagon-like peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease","volume":"9","author":"Bernsmeier","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.metabol.2026.156652_bb0315","doi-asserted-by":"crossref","first-page":"G807","DOI":"10.1152\/ajpgi.00351.2013","article-title":"Chronic high-fat feeding increases GIP and GLP-1 secretion without altering body weight","volume":"309","author":"Wang","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"10.1016\/j.metabol.2026.156652_bb0320","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.metabol.2026.156652_bb0325","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/en.2015-1321","article-title":"Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors","volume":"156","author":"Brighton","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2026.156652_bb0330","first-page":"8","article-title":"High fat diet induces microbiota-dependent silencing of enteroendocrine cells","author":"Ye","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.metabol.2026.156652_bb0335","first-page":"145","article-title":"Dynamics of chromatin marks and the role of JMJD3 during pancreatic endocrine cell fate commitment","author":"Yu","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.metabol.2026.156652_bb0340","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcmgh.2020.08.006","article-title":"Reduced Neurog3 gene dosage shifts enteroendocrine progenitor towards goblet cell lineage in the mouse intestine","volume":"11","author":"Li","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"10.1016\/j.metabol.2026.156652_bb0345","first-page":"5","article-title":"Null mutations of NEUROG3 are associated with delayed-onset diabetes mellitus","author":"Solorzano-Vargas","year":"2020","journal-title":"JCI Insight."},{"key":"10.1016\/j.metabol.2026.156652_bb0350","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s42255-024-01044-5","article-title":"Interaction between the gut microbiota and colonic enteroendocrine cells regulates host metabolism","volume":"6","author":"Tan","year":"2024","journal-title":"Nat Metab."},{"key":"10.1016\/j.metabol.2026.156652_bb0355","first-page":"6","article-title":"Dnmt3a is an epigenetic mediator of adipose insulin resistance","author":"You","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.metabol.2026.156652_bb0360","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1186\/s12876-025-04358-0","article-title":"Efficacy of GLP-1 receptor agonists and dual GLP-1\/GIP receptor agonists in managing MALFD: a meta-analysis of randomized controlled trials","volume":"25","author":"Tamilwanan","year":"2025","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.metabol.2026.156652_bb0365","first-page":"13","article-title":"Alterations in circulating bile acids in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","author":"Lai","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.metabol.2026.156652_bb0370","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156652_bb0375","article-title":"Bile acids contribute to the development of non-alcoholic steatohepatitis in mice","volume":"4","author":"Gillard","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.metabol.2026.156652_bb0380","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","article-title":"Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis","volume":"48","author":"Wouters","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156652_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169268","article-title":"Dietary cholic acid exacerbates liver fibrosis in NASH model of Sprague-Dawley rats fed a high-fat and high-cholesterol diet","volume":"23","author":"Ichimura-Shimizu","year":"2022","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.metabol.2026.156652_bb0390","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12876-025-03903-1","article-title":"Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver disease","volume":"25","author":"Lyu","year":"2025","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.metabol.2026.156652_bb0395","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"issue":"1054\u201362","key":"10.1016\/j.metabol.2026.156652_bb0400","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.metabol.2026.156652_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastha.2025.100783","article-title":"Integrating gut microbiome and metabolome to gain insight into metabolic dysfunction-associated steatotic liver disease","volume":"4","author":"Zhang","year":"2025","journal-title":"Gastro Hep Adv."},{"key":"10.1016\/j.metabol.2026.156652_bb0410","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156652_bb0415","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s44324-024-00022-5","article-title":"Autophagy and hepatic lipid metabolism: mechanistic insight and therapeutic potential for MASLD","volume":"2","author":"Raza","year":"2024","journal-title":"NPJ Metab Health Dis."},{"key":"10.1016\/j.metabol.2026.156652_bb0420","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","article-title":"Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance","volume":"15","author":"Jornayvaz","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.metabol.2026.156652_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.119053","article-title":"Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"400","author":"Iturbe-Rey","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2026.156652_bb0430","first-page":"9","article-title":"Function, detection and alteration of acylcarnitine metabolism in hepatocellular carcinoma","author":"Li","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.metabol.2026.156652_bb0435","article-title":"Lipid metabolism in MASLD and MASH: from mechanism to the clinic","volume":"6","author":"Carli","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/j.metabol.2026.156652_bb0440","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1038\/s41467-024-53670-y","article-title":"Biosynthetic enzyme analysis identifies a protective role for TLR4-acting gut microbial sulfonolipids in inflammatory bowel disease","volume":"15","author":"Older","year":"2024","journal-title":"Nat Commun."},{"key":"10.1016\/j.metabol.2026.156652_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.575595","article-title":"Regulation of enteroendocrine cell networks by the major human gut symbiont Bacteroides thetaiotaomicron","volume":"11","author":"Modasia","year":"2020","journal-title":"Front Microbiol."},{"key":"10.1016\/j.metabol.2026.156652_bb0450","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2026.156652_bb0455","first-page":"151","article-title":"Gut microbiota regulate maturation and mitochondrial function of the nutrient-sensing enteroendocrine cell","author":"Alsudayri","year":"2024","journal-title":"Development"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526001629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526001629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:14:38Z","timestamp":1783156478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526001629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":91,"alternative-id":["S0026049526001629"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156652","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut-liver metabolic and enterohormonal remodeling drives progression from metabolic dysfunction-associated steatotic liver disease to steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156652"}}